Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Honorio Torres-Aguilar

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 18, 2025
Mixed Leukocyte Reaction Using Human Blood Monocyte-Derived Dendritic Cells and Memory CD4<sup>+</sup> T CellsWilliam de Jesús Ríos-Ríos, Honorio Torres-Aguilar
Autoimmunity Reviews|August 4, 2010
Tolerogenic dendritic cells in autoimmune diseases: crucial players in induction and prevention of autoimmunityHonorio Torres-Aguilar, Miri Blank, Luis J Jara, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 18, 2025
Mixed Leukocyte Reaction Using Human Plasmacytoid Dendritic Cells and CD4<sup>+</sup> T CellsSorely Adelina Sosa-Luis, Alexia Almaraz-Arreortua, Honorio Torres-Aguilar
Current Opinion in Rheumatology|May 29, 2019
Infections as triggers of flares in systemic autoimmune diseases: novel innate immunity mechanismsHonorio Torres-Aguilar, Sorely A Sosa-Luis, Sergio R Aguilar-Ruiz
Biomolecules|November 14, 2020
T Cells Subsets in the Immunopathology and Treatment of Sjogren's SyndromeWilliam de Jesús Ríos-Ríos, Sorely Adelina Sosa-Luis, Honorio Torres-Aguilar
World Journal of Diabetes|May 17, 2021
Current advances in using tolerogenic dendritic cells as a therapeutic alternative in the treatment of type 1 diabetesWilliam de Jesús Ríos-Ríos, Sorely Adelina Sosa-Luis, Honorio Torres-Aguilar
Journal of Clinical Immunology|June 15, 2010
IL-10/TGF-beta-treated dendritic cells, pulsed with insulin, specifically reduce the response to insulin of CD4+ effector/memory T cells from type 1 diabetic individualsHonorio Torres-Aguilar, Carmen Sánchez-Torres, Luis J Jara, et al.
Clinical Laboratory|August 16, 2019
Evaluation of the Interference of Lipemia and Hemolysis in the Detection Limit of Anti-HIV-1 AntibodiesPaola S Mendoza-Benitez, Sergio R Aguilar-Ruiz, María Dla Romero-Tlalolini, et al.
Annals of the Rheumatic Diseases|September 15, 2011
Tolerogenic dendritic cells inhibit antiphospholipid syndrome derived effector/memory CD4⁺ T cell response to β2GPIHonorio Torres-Aguilar, Miri Blank, Shaye Kivity, et al.
International Journal of Molecular Sciences|October 13, 2021
Recent Advances in the Discovery and Function of Antimicrobial Molecules in PlateletsAlba S Aquino-Domínguez, María de Los A Romero-Tlalolini, Honorio Torres-Aguilar, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|March 18, 2025
Mixed Leukocyte Reaction Using Human Blood Monocyte-Derived Dendritic Cells and Memory CD4<sup>+</sup> T CellsWilliam de Jesús Ríos-Ríos, Honorio Torres-Aguilar
Autoimmunity Reviews|August 4, 2010
Tolerogenic dendritic cells in autoimmune diseases: crucial players in induction and prevention of autoimmunityHonorio Torres-Aguilar, Miri Blank, Luis J Jara, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 18, 2025
Mixed Leukocyte Reaction Using Human Plasmacytoid Dendritic Cells and CD4<sup>+</sup> T CellsSorely Adelina Sosa-Luis, Alexia Almaraz-Arreortua, Honorio Torres-Aguilar
Current Opinion in Rheumatology|May 29, 2019
Infections as triggers of flares in systemic autoimmune diseases: novel innate immunity mechanismsHonorio Torres-Aguilar, Sorely A Sosa-Luis, Sergio R Aguilar-Ruiz
Biomolecules|November 14, 2020
T Cells Subsets in the Immunopathology and Treatment of Sjogren's SyndromeWilliam de Jesús Ríos-Ríos, Sorely Adelina Sosa-Luis, Honorio Torres-Aguilar
World Journal of Diabetes|May 17, 2021
Current advances in using tolerogenic dendritic cells as a therapeutic alternative in the treatment of type 1 diabetesWilliam de Jesús Ríos-Ríos, Sorely Adelina Sosa-Luis, Honorio Torres-Aguilar
Journal of Clinical Immunology|June 15, 2010
IL-10/TGF-beta-treated dendritic cells, pulsed with insulin, specifically reduce the response to insulin of CD4+ effector/memory T cells from type 1 diabetic individualsHonorio Torres-Aguilar, Carmen Sánchez-Torres, Luis J Jara, et al.
Clinical Laboratory|August 16, 2019
Evaluation of the Interference of Lipemia and Hemolysis in the Detection Limit of Anti-HIV-1 AntibodiesPaola S Mendoza-Benitez, Sergio R Aguilar-Ruiz, María Dla Romero-Tlalolini, et al.
Annals of the Rheumatic Diseases|September 15, 2011
Tolerogenic dendritic cells inhibit antiphospholipid syndrome derived effector/memory CD4⁺ T cell response to β2GPIHonorio Torres-Aguilar, Miri Blank, Shaye Kivity, et al.
International Journal of Molecular Sciences|October 13, 2021
Recent Advances in the Discovery and Function of Antimicrobial Molecules in PlateletsAlba S Aquino-Domínguez, María de Los A Romero-Tlalolini, Honorio Torres-Aguilar, et al.
Pageof 4